Delivery Order SPE2DB22D2211-SPE2DB25FRYJL
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,403.92 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 14, 2025. The contract has an ultimate completion date of March 17, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has a ceiling value of $15,481.50 and a completion date of June 9, 2025. It is a Firm Fixed Price delivery order contract, with no set-aside designation. Amerisourcebergen Drug...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA). The $26,599.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $10,523.47, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of December 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $43,458.91 firm fixed-price delivery order contract has a completion date of June 5, 2025 and was awarded on June 4, 2025 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This contract is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $24,270.29 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a June 7, 2023 completion date and is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $44,914.98 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2024, with a completion date of May 3, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $23,765.86 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,862.89 and a completion date of October 21, 2024. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the procurement of BIKTARVY 50-200-25 MG TABLET UU 30S medical products by the Defense Logistics Agency (DLA). The $4,657.14 firm fixed-price delivery order was awarded to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 27, 2025 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...